Pierre Goldbach,Hanns-Christian Mahler,Robert Mueller
申请号：
US14381849
公开号：
US20150030589A1
申请日:
2013.03.05
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention relates to a pharmaceutical formulation comprising about 50 mg/ml-200 mg/ml of an Abeta antibody, about 0.01%-0.1% poloxamer, about 5 mM-50 mM of a buffer, about 100 mM-300 mM of a stabilizer at a pH of about 4.5-7.0.
